DK652687A - Farmaceutisk sammensaetning omfattende azumolen - Google Patents

Farmaceutisk sammensaetning omfattende azumolen

Info

Publication number
DK652687A
DK652687A DK652687A DK652687A DK652687A DK 652687 A DK652687 A DK 652687A DK 652687 A DK652687 A DK 652687A DK 652687 A DK652687 A DK 652687A DK 652687 A DK652687 A DK 652687A
Authority
DK
Denmark
Prior art keywords
azumol
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK652687A
Other languages
Danish (da)
English (en)
Other versions
DK652687D0 (da
Inventor
Schwe Fang Pong
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK652687D0 publication Critical patent/DK652687D0/da
Publication of DK652687A publication Critical patent/DK652687A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK652687A 1986-12-12 1987-12-11 Farmaceutisk sammensaetning omfattende azumolen DK652687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/940,815 US4822629A (en) 1986-12-12 1986-12-12 Azumolene dosage form

Publications (2)

Publication Number Publication Date
DK652687D0 DK652687D0 (da) 1987-12-11
DK652687A true DK652687A (da) 1988-06-13

Family

ID=25475467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK652687A DK652687A (da) 1986-12-12 1987-12-11 Farmaceutisk sammensaetning omfattende azumolen

Country Status (8)

Country Link
US (1) US4822629A (de)
EP (1) EP0271151A3 (de)
JP (1) JPS63198625A (de)
AU (1) AU596929B2 (de)
DK (1) DK652687A (de)
IL (1) IL84659A (de)
MY (1) MY100780A (de)
ZA (1) ZA879328B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536277A1 (de) * 1990-06-25 1993-04-14 The Du Pont Merck Pharmaceutical Company Amantadin hydrochlorid enthaltende pharmazeutische suspension mit erhöhter auflösbarkeit für weichgelatinekapseln
US5175002A (en) * 1991-10-02 1992-12-29 Du Pont Merck Pharmaceutical Company Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
IT1291652B1 (it) * 1997-04-24 1999-01-19 Apr Trading Sa Composizioni farmaceutiche a copertura terapeutica programmata
JP4939680B2 (ja) * 1997-05-27 2012-05-30 武田薬品工業株式会社 固形製剤
WO2009022670A1 (ja) * 2007-08-10 2009-02-19 Takeda Pharmaceutical Company Limited 速崩壊性錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
US4049650A (en) * 1976-10-18 1977-09-20 Morton-Norwich Products, Inc. 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4457907A (en) * 1982-08-05 1984-07-03 Clear Lake Development Group Composition and method for protecting a therapeutic drug
US4543359A (en) * 1982-10-01 1985-09-24 Eaton Laboratories, Inc. Treating cardiac arrhythmias with dantrolene sodium
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms

Also Published As

Publication number Publication date
EP0271151A2 (de) 1988-06-15
IL84659A0 (en) 1988-04-29
US4822629A (en) 1989-04-18
EP0271151A3 (de) 1988-07-27
IL84659A (en) 1992-01-15
MY100780A (en) 1991-02-14
DK652687D0 (da) 1987-12-11
JPS63198625A (ja) 1988-08-17
AU8245287A (en) 1988-06-16
ZA879328B (en) 1988-08-31
AU596929B2 (en) 1990-05-17

Similar Documents

Publication Publication Date Title
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
KR880005932A (ko) 신경중독손상을 감소시키기 위한 약제 조성물
DK195988D0 (da) Farmaceutisk praeparat indeholdende mikrokapsler
BR8700056A (pt) Composicao organopolisiloxano
IT1211967B (it) Composizione farmaceutica contenente ranitidina
IT1209615B (it) Composizione farmaceutica
DK652687A (da) Farmaceutisk sammensaetning omfattende azumolen
BR8704087A (pt) Composicao
MX5577A (es) Formulacion farmaceutica
DK142487D0 (da) Farmaceutiske midler
MX11584A (es) Composiciones farmaceuticas
RO95836A (ro) Compozitie erbicida lichida
LV5649A3 (lv) Herbicida kompozicija
IT1216814B (it) Composizioni farmaceutiche
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DK428287A (da) Nasalt farmaceutisk praeparat
IT9020332A0 (it) Composizione farmaceutica
SE8904063D0 (sv) Farmaceutisk komposition
BR1100961A (pt) Composto e composição farmacêutica
SE8705100D0 (sv) Farmaceutisk komposition
SE8700576D0 (sv) Pharmaceutical composition
DK611887D0 (da) Farmaceutiske materialer
LV5728B4 (lv) Farmaceitiskas kompozicijas

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment